Comparison of effects of 2 harvesting methods on fat autograft.
Park H., Williams R., Goldman N., Choe H., Kobler J., Lopez-Guerra G.
Animal Study with a reported sample of 5, published in Laryngoscope (2008) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- Laryngoscope (2008)
- Country
- United States
- Reported sample size
- 5
- Source database
- PubMed
- PMID
- 18496155
- DOI
- 10.1097/MLG.0b013e3181735634
Abstract (original English)
Fat preparation for vocal-fold injection medialization is typically done by scraping of excised fat or by lipo-aspiration; however, lipo-aspiration is substantially more efficient. Considering this, we compared viability of fat tissues obtained by these two techniques. We also examined whether basic fibroblast growth factor (bFGF) would increase cell proliferation in samples harvested by these methods. Harvesting techniques (scraping and lipo-aspiration) were compared using both human and ferret fat. In vitro assays were used to assess tissue viability and cell proliferation. Human (n = 5) and ferret (n = 15) abdominal fat specimens were harvested by scraping and lipo-aspiration, for a total of 40 specimens. Alamar Blue and glycerol-3-phosphate dehydrogenase assays were used to quantitatively assess metabolic activity and cellular damage immediately after harvest. PicoGreen assays assessed cell proliferation by quantifying total DNA in harvested specimens after 0, 14, or 21 days in culture. The effects of bFGF (10 ng/mL) on proliferation were measured for the same timepoints. The glycerol-3-phosphate dehydrogenase assay indicated that lipo-aspiration caused more initial tissue damage (12 +/- 5 mU/mL) than scraping (5 +/- 3 mU/mL), but cell metabolic activity was similar in both groups based on the Alamar Blue assay. Cell proliferation at 14 and 21 days was significantly higher
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.